Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07557589

Radiofrequency Treatment for Pilonidal Disease : Clinical Investigation on Safety of Use, Efficacy and Patient Satisfaction at 6 Months

Infected pilonidal sinus is a common suppuration that occurs twice as often in men as in women, usually between the ages of 15 and 30. Clinical diagnosis is easy, whether the presentation is acute or chronic. Exeresis with a wound left open requiring secondary postoperative healing is the most widely practiced technique in France because its recurrence rate is the lowest, but it has the disadvantage of requiring daily or even twice-daily local nursing care, long healing, and a break in activity.

In order to limit the disadvantages of the open technique, "conservative" minimally invasive techniques have also recently been developed in response to strong patient demand: such as endoscopic treatment (EPSIT = Endoscopic Pilonidal Sinus Treatment, or VAAPS = Video-Assisted Ablation of Pilonidal Sinus), or the SiLaT (Sinus Laser Therapy) laser.

More recently, radiofrequency has emerged as a new technique in the treatment of hemorrhoidal pathology according to the Rafaelo procedure as well as the Fistura procedure for anal fistulas. The principle of the treatment is similar to that of the laser, based on radio frequency thermocoagulation using very high frequency electromagnetic waves (4MHz), similar to the principle of microwaves. However, its use in the infected pilonidal sinus has not yet been described. The fibers used in anal fistulas are perfectly adapted to the treatment of the pilonidal sinus. In addition, and in contrast to the laser, several fiber diameters are available depending on the size of the fistula path(s). For example, the large diameters of 9 Fr seem to be more adapted to the deep and wide cavities of the pilonidal sinuses than those of the SiLaT, which has a single fiber diameter. The investigators can therefore think that this type of fibers could allow a more efficient destruction of the granulation tissues and a better docking of the cavity walls.

According to published studies in the treatment of anal fistulas, the safety profile of this treatment is perfectly reassuring since the penetrance of the energy released does not exceed 3 mm in depth.

The aim of this study is to evaluate the radiofrequency treatment according to the Fistura® procedure, by mesure its safety, efficacy and patient satisfaction on a series of consecutive patients treated for infected sinus pilonidal.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre Hospitalier de Dax, Dax, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient presenting an infected pilonidal sinus at the exception of acute abscess stage requiring an surgical procedure
  • Patient aged 18 or above
  • For Women Of Child Bearing Age, use of efficient contraceptive (less than 1% failure)
  • Patient with health insurance coverage
  • French-speaking patient
  • Patient who has given their free, informed and written consent

Exclusion criteria

  • Patient already included in a type 1 interventional research protocol (RIPH1)
  • Patient with cardiac disease (including pacemaker)
  • Patient with skin infection
  • Patient with acute abcess
  • Patient with suppurated cavity requiring urgent drainage
  • Patient for whom local or general anesthesia is contraindicated, with an anal infectious disease, or an anal fissure or who have previously had a stapled hemorrhoidopexy (Longo procedure) with metallic staples
  • Patient treated by aspririn or anticoagulant
  • Patient with bleeding or coagulation disorder
  • Allergic patient to nickel and chromium
  • Pregnant or Breastfeeding women
  • Patient under guardianship or curatorship
  • Patient incarcerated
  • Patient under legal protection
  • Patient refusing follow-up
  • Patient for whom MRI is contraindicated

Treatment and study plan

Radiofrequency treatment

Device

Radiofrequency using the Fistura procedure for treatment of infected pilonidal sinus

Primary outcomes

  1. Evaluation of radiofrequency treatment safety

    Time frame: Within 15days after the radiofrequency treatment

    Incidence rate of at least one complication of the radiofrequency treatment : incidence rate of of haemorrhagic complication, incidence rate of acute urinary retention and incidence rate of others complications such as post radiofrequency treatment abcess, haematoma, localized infection.

Secondary outcomes

  1. Evaluation of radiofrequency treatment safety

    Time frame: Within 15days after the radiofrequency treatment

    Incidence rate of of haemorrhagic complication after the radiofrequency treatment

  2. Evaluation of radiofrequency treatment safety

    Time frame: Within 15days after the radiofrequency treatment

    Incidence rate of acute urinary retention after the radiofrequency treatment

  3. Evaluation of radiofrequency treatment safety

    Time frame: Within 15days after the radiofrequency treatment

    Incidence rate of others complications such as post radiofrequency treatment abcess, haematoma, localized infection.

  4. Evaluation of post radiofrequency pain

    Time frame: Within 15days after the radiofrequency treatment

    Patient will be asked daily to evaluate post surgery pain using a Numerical Rating Scale (NRS). Patients will be asked to circle the number between 0 and 10 that fits best to their pain intensity. Zero represents 'no pain at all' whereas10 represents 'the worst pain ever possible'.

  5. Evaluation of radiofrequency treatment efficiency

    Time frame: 6 months after the radiofrequency treatment

    During the last patient visit, a clinical evaluation will be performed during which closure of all existing fistula external opening will be assessed (Yes or No), as well as the absence or presence of abcess and new external opening (Yes or no) . The patient will be asked to evaluate the presence or absence of pain (yes or no)

    The Treatment will be evaluated as efficient if there is closure of all fistula external opening AND absence of pain AND absence of abscess or new external opening.

  6. Length of the medical leave after the radiofrequency treatment

    Time frame: Within 6 months after the radiofrequency treatment

    Record of number of medical leave days prescribed after the radiofrequency treatment Record of number of day after the radiofrequency treatmenty necessary before returning to normal activity.

  7. Measurement of patient satisfaction after the radiofrequency treatment

    Time frame: At 1 mont and 6 months after the radiofrequency treatment

    Each patient will evaluate their satisfaction regarding their radiofrequency treatment using a visual 5 point scale ranking from "very unsatified" to "very satisfied"

Sponsors and collaborators

Lead sponsor

CHI MONT DE MARSAN ET PAYS DES SOURCES

Other

Collaborators

  • Centre Hospitalier de Dax

Registry information

Acronym: RFKP

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Apr 29, 2026
Registry last updated
May 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.